Content
On a research treatment day, monitoring follows the study protocol and clinic procedures. Delegated staff observe the items the protocol requires, document what occurs, and bring concerns to the appropriate clinician or investigator. The exact stages vary by study, so the study team is the right source for the timing, instructions, and practical questions that apply to your scheduled research visit.
Monitoring means staff are actively following the assigned observation process during the visit rather than leaving you to manage questions alone. They may use required checklists, record observations, and communicate information through the study and clinic team. An adverse-event observation is information that the study process requires staff to document and route; it is not a diagnosis or a conclusion about what caused it.
Delegated staff may support the flow of SPRAVATO® or IV ketamine visits, required checklists, observation, and documentation when trained and assigned to do so. They do not independently determine research eligibility, dosing, or treatment decisions. Investigators retain clinical judgment and direct the study-related and clinical decisions within their responsibilities.
Before the visit, write down practical questions: What stages will the day include? What will staff monitor? Who should I tell if I notice a change or have a question? How long should I reserve? Who can explain a study procedure before I arrive? Ask the study team how to contact them through the designated channel if you need clarification before treatment day.
During the visit, report changes and questions as they occur rather than waiting until the end. Use your own words; you do not need to decide whether something is important enough to mention. Staff can document the information and route it through the study and clinic process. Bring any remaining practical questions to the study team before you leave or before the next scheduled visit.